AHA Letter on Drug Price Transparency Bill

AHA letter to Ways and Means Committee on the Prescription Drug Sunshine, Transparency, Accountability and Reporting Act (H.R. 2113.

Related Resources

Letter/Comment
Public
AHA comments on provisions of the Reauthorizing and Extending America’s Community Health (REACH) Act.
Special Bulletin
Member
The White House June 24 released an executive order on “improving price and quality transparency in American health care.” The executive order focu
Letter/Comment
Public
The AHA voices support for legislation (S. 1399) to revise and extend federal programs to develop the nursing workforce recently introduced by Sens. Jeff…
Letter/Comment
The AHA today submitted comments to the Senate Health, Education, Labor and Pensions Committee on their bipartisan discussion draft legislation, the Lower…
Letter/Comment
Public
AHA letter to Representative Eliot Engel expressing support H.R. 3022, the Patient Access Protection Act, legislation to repeal the Medicaid Disproportionate…
Special Bulletin
Member
Leaders of the Senate Committee on Health, Education, Labor and Pensions (HELP) May 23 released the Lower Health Care Costs Act of 2019 – bipartisan discussion…